My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eledon Pharmaceuticals, Inc. - Common Stock (NQ:ELDN)

1.640 +0.070 (+4.46%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Eledon Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

ELDN Stock Earnings: Eledon Pharma Beats EPS for Q4 2023 ↗

March 28, 2024

ELDN stock results show that Eledon Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Kidney Transplant From Genetically Edited Pig: Boston Patient With End-Stage Renal Disease Becomes First To Receive ↗

March 21, 2024

Eledon Pharmaceuticals announces successful use of tegoprubart in kidney xenotransplant. Promising results show its potential to prevent rejection, marking a significant milestone in organ...

Via Benzinga

Expert Ratings for Eledon Pharma ↗

November 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 02, 2023

Via Benzinga

Recap: Eledon Pharma Q1 Earnings ↗

May 11, 2023

Via Benzinga

Eledon Pharma's Earnings: A Preview ↗

May 10, 2023

Via Benzinga

Eledon Pharmaceuticals's Earnings: A Preview ↗

March 29, 2023

Via Benzinga

Eledon Pharma: Q2 Earnings Insights ↗

August 11, 2022

Eledon Pharma (NASDAQ:ELDN) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗

September 27, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 25, 2023

On Tuesday, 56 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 15, 2023

On Thursday, 64 companies achieved new lows for the year.

Via Benzinga

Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

June 01, 2023

Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 58.9% to $0.3754 in pre-market trading. Airspan Networks recently reported new financing and leadership changes.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 01, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers that traders need to know about for Thursday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 21, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 06, 2022

Gainers Metacrine (NASDAQ:MTCR) shares rose 13.8% to $0.54 during Tuesday's after-market session. This security traded at a volume of 3.0 million shares come close, making up 948.6% of its average...

Via Benzinga

Eledon Shares Climb After Securing FDA Nod For Mid-Stage Kidney Disease Study ↗

September 06, 2022

Eledon Pharmaceuticals (NASDAQ: ELDN) received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to evaluate tegoprubart for the treatment of...

Via Benzinga

Eledon Pharmaceuticals Earnings: A Preview ↗

August 10, 2022

Eledon Pharmaceuticals (NASDAQ:ELDN) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 01, 2022

Via Benzinga

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial ↗

August 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Eledon Secures FDA Clearance For Kidney Transplant Rejection Study ↗

August 01, 2022

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ: ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ...

Via Benzinga

Recap of Monday's Biotech Catalysts - End of the Day Summary ↗

July 18, 2022

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...

Via Benzinga

Eledon Pharmaceuticals' Stock Gains As FDA Grants Orphan Drug Designation ↗

June 09, 2022

Eledon Pharmaceuticals (NASDAQ: ELDN) received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate Tegoprubart for the Prevention of Allograft Rejection in...

Via Benzinga

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗

June 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 07, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 31, 2022

Via Benzinga

Eledon Pharma: Q1 Earnings Insights ↗

May 12, 2022

Eledon Pharma (NASDAQ:ELDN) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Eledon Pharma missed estimated...

Via Benzinga

88 Biggest Movers From Yesterday ↗

May 27, 2022

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.